Tuberculosis and Childhood Cancer in Asia: Physician Perspectives on Diagnostic Delay and Treatment Interference

Background: Tuberculosis (TB) and childhood cancer frequently coexist in Asia, a region bearing a disproportionate burden of both diseases. Clinical overlap between TB and malignancy, combined with limitations in diagnostic tools and high community prevalence, may delay cancer diagnosis and compromise treatment delivery. Physician-level data describing these challenges remain limited. Methods: A cross-sectional, web-based survey was conducted among pediatric oncology physicians practicing in Asia between July and September 2023. The anonymous survey assessed clinicians’ experiences and reported center-level practices across four domains: diagnostic overlap and delay, modifications or interruptions to cancer treatment, potential drug-drug interactions between antitubercular therapy and chemotherapy, and TB screening practices. Descriptive analyses were performed. Ethics approval was obtained, and participation was voluntary and anonymous, with informed consent implied by survey completion. Results: Forty-one responses from 25 countries were analyzed. All respondents managed both hematologic malignancies and solid tumors. Proven TB coexisting with cancer was reported in fewer than 10% of patients; however, empirical antitubercular therapy prior to cancer diagnosis was common. Hodgkin lymphoma was most frequently misdiagnosed as TB (n = 37, 90.2%). Overlapping constitutional symptoms and radiologic findings were the predominant contributors to diagnostic error. Treatment interruptions related to drug-drug interactions were reported by 65.8% of respondents (n = 27), and 44% (n = 18) reported modifying cancer therapy intensity. Routine TB screening prior to cancer treatment was not practiced, except selectively before hematopoietic stem cell transplantation. Conclusions: TB substantially influences diagnostic pathways and treatment delivery for childhood cancer across Asia. Empirical TB treatment often delays cancer diagnosis, while TB diagnosed during therapy disrupts oncologic management. These findings underscore the need for standardized diagnostic algorithms and prospective studies to guide integrated TB-cancer care in children.

Authors

Publication Details

Journal
Cureus
Published
2026-11-20
DOI
https://doi.org/10.7759/cureus.120025
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tuberculosis and Childhood Cancer in Asia: Physician Perspectives on Diagnostic Delay and Treatment Interference

Nita Radhakrishnan, M Caniza, Ankit Kumar
Cureus
Tuberculosis Research and Epidemiology
article

Tuberculosis and Childhood Cancer in Asia: Physician Perspectives on Diagnostic Delay and Treatment Interference

Nita Radhakrishnan, M Caniza, Ankit Kumar
article en

Abstract

Background: Tuberculosis (TB) and childhood cancer frequently coexist in Asia, a region bearing a disproportionate burden of both diseases. Clinical overlap between TB and malignancy, combined with limitations in diagnostic tools and high community prevalence, may delay cancer diagnosis and compromise treatment delivery. Physician-level data describing these challenges remain limited. Methods: A cross-sectional, web-based survey was conducted among pediatric oncology physicians practicing in Asia between July and September 2023. The anonymous survey assessed clinicians’ experiences and reported center-level practices across four domains: diagnostic overlap and delay, modifications or interruptions to cancer treatment, potential drug-drug interactions between antitubercular therapy and chemotherapy, and TB screening practices. Descriptive analyses were performed. Ethics approval was obtained, and participation was voluntary and anonymous, with informed consent implied by survey completion. Results: Forty-one responses from 25 countries were analyzed. All respondents managed both hematologic malignancies and solid tumors. Proven TB coexisting with cancer was reported in fewer than 10% of patients; however, empirical antitubercular therapy prior to cancer diagnosis was common. Hodgkin lymphoma was most frequently misdiagnosed as TB (n = 37, 90.2%). Overlapping constitutional symptoms and radiologic findings were the predominant contributors to diagnostic error. Treatment interruptions related to drug-drug interactions were reported by 65.8% of respondents (n = 27), and 44% (n = 18) reported modifying cancer therapy intensity. Routine TB screening prior to cancer treatment was not practiced, except selectively before hematopoietic stem cell transplantation. Conclusions: TB substantially influences diagnostic pathways and treatment delivery for childhood cancer across Asia. Empirical TB treatment often delays cancer diagnosis, while TB diagnosed during therapy disrupts oncologic management. These findings underscore the need for standardized diagnostic algorithms and prospective studies to guide integrated TB-cancer care in children.

Cureus
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Tuberculosis and Childhood Cancer in Asia: Physician Perspectives on Diagnostic Delay and Treatment Interference — Nita Radhakrishnan, M Caniza, et al. · Cureus (2026) | TGRS Research Map | TGRS